To the best of our knowledge, only one study in the literature evaluated the immunohistochemical expression of MMP-2 in breast cancer and fibroadenoma and showed that a high expression of MMP-2 in breast ductal carcinoma in situ was an early incident in the genetic course of the breast cancer [24]. The gene discussed is MMP2; the disease is ductal breast carcinoma in situ.